Robert Truckenmiller is Senior Vice President & Head of the U.S. Oncology Franchise and Market Access & Customer Solutions at EMD Serono.
In his role as Senior Vice President & Head of the U.S. Oncology Franchise, Rob is responsible for leading the strategic direction of the Oncology business in the U.S.
In addition, Rob serves as the Head of Market Access & Customer Solutions at EMD Serono. In this role, he manages the development of U.S. market access strategies across all EMD Serono medications.
Before joining EMD Serono, Rob served as Vice President and Head of the U.S. Market Access & Pricing at UCB, where he led a large team in developing a market access strategy that successfully improved overall patient access to UCB brands. He spent eleven years at UCB, taking on roles of increasing responsibility across market access and brand marketing.
Rob has more than 15 years of experience in the biopharmaceutical industry in various sales and marketing roles at companies such as Johnson & Johnson and DaVita Kidney Care. Additionally, Rob is a six-year veteran of the U.S. Coast Guard.
Rob holds an undergraduate degree in Marketing and an MBA in Finance and Financial Management Services from University of Central Florida - College of Business Administration.